Singapore markets close in 6 hours 12 minutes
Straits Times Index
3,302.72 -11.33 (-0.34%) Nikkei
39,141.19 +71.51 (+0.18%) Hang Seng
19,246.97 -389.25 (-1.98%) FTSE 100
8,424.20 +3.94 (+0.05%) Bitcoin USD
71,259.78 +4,595.01 (+6.89%) CMC Crypto 200
1,509.25 +154.83 (+11.43%)
MEI Pharma, Inc. (MEIP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 20.99M |
| Enterprise value | -23.90M |
| Trailing P/E | 0.80 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.31 |
| Price/book (mrq) | 0.41 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.70 |
| 52-week change 3 | -57.92% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 7.9700 |
| 52-week low 3 | 2.8700 |
| 50-day moving average 3 | 3.4778 |
| 200-day moving average 3 | 5.3243 |
Share statistics
| Avg vol (3-month) 3 | 20k |
| Avg vol (10-day) 3 | 18.65k |
| Shares outstanding 5 | 6.66M |
| Implied shares outstanding 6 | 6.66M |
| Float 8 | 4.94M |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 43.33% |
| Shares short (30 Apr 2024) 4 | 22.83k |
| Short ratio (30 Apr 2024) 4 | 1.36 |
| Short % of float (30 Apr 2024) 4 | 0.41% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.34% |
| Shares short (prior month 28 Mar 2024) 4 | 7.83k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 06 Dec 2023 |
| Ex-dividend date 4 | 16 Nov 2023 |
| Last split factor 2 | 1:20 |
| Last split date 3 | 17 Apr 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 39.18% |
| Operating margin (ttm) | 30.53% |
Management effectiveness
| Return on assets (ttm) | 12.40% |
| Return on equity (ttm) | 61.26% |
Income statement
| Revenue (ttm) | 66.75M |
| Revenue per share (ttm) | 10.02 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | 20.73M |
| Net income avi to common (ttm) | 26.16M |
| Diluted EPS (ttm) | 3.9200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 56.55M |
| Total cash per share (mrq) | 8.49 |
| Total debt (mrq) | 11.67M |
| Total debt/equity (mrq) | 22.86% |
| Current ratio (mrq) | 6.17 |
| Book value per share (mrq) | 7.66 |
Cash flow statement
| Operating cash flow (ttm) | -43.78M |
| Levered free cash flow (ttm) | 7.19M |
© 2024 Yahoo. All rights reserved.